www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

ALK — Financial calendar for the 2016 financial year

December 15, 2015

PDF Version

Supporting Materials:
FM_22_15UK_16122015.pdf

 

 

Copenhagen, 2015-12-15 09:00 CET (GLOBE NEWSWIRE) --  

2016 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): 

  • Silent period                                                       12 January 2016
  • Annual report 2015                                             9 February 2016
  • Annual General Meeting to be held                      10 March 2016
    at ALK                                                                            4.00 p.m.
    Bøge Allé 1
    2970 Hørsholm, Denmark

    Written requests to have specific business
    transacted at the AGM will be included in the agenda
    if received by the company on 27 January 2016 at the latest
    (may be e-mailed to investor@alk.net)
     
  • Silent period                                                             5 April 2016
  • Three-month interim report (Q1) 2016                      4 May 2016
  • Silent period                                                            19 July 2016
  • Six-month interim report (Q2) 2016                    16 August 2016
  • Silent period                                                      13 October 2016
  • Nine-month interim report (Q3) 2016            10 November 2016

 

  ALK-Abelló A/S

   

For further information please contact:
Per Plotnikof, VP Corporate Communications, IR and Strategic Planning, tel. +45 4574 7527

 

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved